Cargando…
Evaluation of PIMA Point-of-care CD4 Analyzer in Yunnan, China
BACKGROUND: CD4 count is used to determine antiretroviral therapy (ART) eligibility. In China, flow cytometers are mostly located in urban areas with limited access by patients residing in remote areas. In an attempt to address this issue, we conducted a study to validate the performance of Alere PI...
Autores principales: | Liang, Jun, Duan, Song, Ma, Yan-Ling, Wang, Ji-Bao, Su, Ying-Zhen, Zhang, Hui, Ou, Chin-Yih, Hao, Ling, Qi, Ming-Shan, Bulterys, Marc, Westerman, Larry, Jiang, Yan, Xiao, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834004/ https://www.ncbi.nlm.nih.gov/pubmed/25836608 http://dx.doi.org/10.4103/0366-6999.154283 |
Ejemplares similares
-
A meta-analysis of the performance of the Pima(TM) CD4 for point of care testing
por: Scott, Lesley E., et al.
Publicado: (2015) -
Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India
por: Thakar, Madhuri, et al.
Publicado: (2012) -
Onsite healthcare worker acceptability and performance of the point-of-care Pima CD4 assay in Dar es Salaam, Tanzania
por: Schmitz, Mary E., et al.
Publicado: (2019) -
Evaluation of Specimen Types for Pima CD4 Point-of-Care Testing: Advantages of Fingerstick Blood Collection into an EDTA Microtube
por: Kohatsu, Luciana, et al.
Publicado: (2018) -
Field Evaluation of PIMA Point-of-Care CD4 Testing in Rakai, Uganda
por: Galiwango, Ronald M., et al.
Publicado: (2014)